Study assessments
Patients were followed up for 12 months from the first PLX-R18 administration. Study visits occurred after PLX-R18 administration on days 0 (first PLX-R18 administration), 1, 7 (second PLX-R18 administration), 8, 14 and 28 and thereafter at month 3, 6, 9 and 12. A full schedule of assessments is included in Table 